SCHEMBL19398239

SCHEMBL19398239

CC1=Nc2cc(Br)ccc2C=C(C(=O)O)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.35
SIRT5 Q9NXA8 1/20 0.35
RXFP1 Q9HBX9 2/20 0.34
PRNP P04156 1/20 0.34
PPARG P37231 1/20 0.34
NR2E3 Q9Y5X4 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
ALDH1A1 P00352 3/20 0.33
HTT P42858 1/20 0.33
MYC P01106 1/20 0.33
NR4A1 P22736 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
TLR8 Q9NR97 8/20 0.32
TLR7 Q9NYK1 4/20 0.32
KDM4E B2RXH2 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GLA P06280 1/20 0.32
SRD5A1 P18405 1/20 0.31
SRD5A2 P31213 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1093647 0.84 TLR8 (0.42) TLR8TLR7KDM4EGLA
SCHEMBL19398238 0.83 TLR8 (0.49) RECQLALDH1A1HTTMEN1KMT2A
SCHEMBL19398240 0.80 TLR8 (0.54) TLR8TLR7
SCHEMBL18759358 0.79 TLR8 (0.35) TLR8TLR7
SCHEMBL1235939 0.75 TLR8 (0.48) RECQLTLR8SMN1; SMN2NPC1
SCHEMBL12237688 0.73 SRD5A1 (0.44) ALDH1A1MYCNR4A1MEN1KMT2A
SCHEMBL10325465 0.72 KDM4E (0.39) ALDH1A1TLR8TLR7KDM4ESMN1; SMN2
SCHEMBL3093660 0.70 SRD5A1 (0.40) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL10326443 0.67 CMA1 (0.51) ALDH1A1HTTMEN1KMT2AKDM4E
SCHEMBL31259524 0.67 CMA1 (0.51) ALDH1A1HTTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180194735-A1 Sulfinylphenyl or Sulfonimidoylphenyl Benzazepines HOFFMANN LA-ROCHE INC. (US) 2018-07-12 US disclosed
US-9890124-B2 Benzazepine sulfonamide compounds HOFFMANN-LA ROCHE INC. (US) 2018-02-13 US disclosed
US-20170275253-A1 BENZAZEPINE SULFONAMIDE COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275253-A1 BENZAZEPINE SULFONAMIDE COMPOUNDS TLR8, TLR7, TLR5 RECQL 3762/4885SIRT5 663/4885RXFP1 207/4885
US-20180194735-A1 Sulfinylphenyl or Sulfonimidoylphenyl Benzazepines TLR1, TLR4, TLR5 RECQL 2822/4885SIRT5 2073/4885RXFP1 217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.